Lung Cancer Immunotherapy in Elderly Patients: Cause for Optimism? – Cancer Therapy Advisor
Cancer Therapy Advisor |
Lung Cancer Immunotherapy in Elderly Patients: Cause for Optimism?
Cancer Therapy Advisor Targeted and immunotherapies appear to be opening a new frontier in the management of elderly patients. Lung cancer is common among elderly patients (those aged 70 years or older). Yet because clinical cancer trials tend to enroll younger patients and … |
